In a report issued on January 25, Larry Biegelsen from Wells Fargo maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), with a price target of $190.00. The company's shares closed last Wednesday at $168.38. According to TipRanks.com, Biegelsen is a 5-star analyst with an average return of 16.5% and a 62.5% success rate. Biegelsen covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Inspire Medical Systems, and Zimmer Biomet Holdings. Johnson & Johnson has an analyst consensus of Strong Buy, with a price target consensus of $188.13, representing a 12.3% upside.
https://www.tipranks.com/news/blurbs/wells-fargo-remains-a-buy-on-johnson-johnson-jnj?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2022 to May 2022 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From May 2021 to May 2022 Click Here for more Johnson and Johnson Charts.